Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StatHIV trial of rosuvastatin for immune activation in treatment-naive HIV
NL-OMON23117Not yet recruiting
- Sponsor
- Stichting Research Interne Geneeskunde
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rosuvastatin in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Stichting Research Interne Geneeskunde. Primary endpoints: Circulating lipopolysaccharide, TLR mRNA expression in whole blood and 6 more. Planned start Oct 2010; status: not yet recruiting.
02
Drugs
rosuvastatin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON23117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23117.